Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic Effects against Pain
暂无分享,去创建一个
Jingze Liu | R. Lai | Pengpeng Li | M. Rong | Bo Chen | Xiong-zhi Zeng | Juan Huang
[1] S. Waxman,et al. Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial , 2017, The Lancet Neurology.
[2] A. Gibbs,et al. Insensitivity to pain induced by a potent selective closed-state Nav1.7 inhibitor , 2017, Scientific Reports.
[3] A. Crameri,et al. Engineering Highly Potent and Selective Microproteins against Nav1.7 Sodium Channel for Treatment of Pain* , 2016, The Journal of Biological Chemistry.
[4] J. Wood,et al. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief , 2016, Expert opinion on therapeutic targets.
[5] L. Poppe,et al. Single Residue Substitutions That Confer Voltage-Gated Sodium Ion Channel Subtype Selectivity in the NaV1.7 Inhibitory Peptide GpTx-1. , 2016, Journal of medicinal chemistry.
[6] Paul F. Alewood,et al. Analgesic Effects of GpTx-1, PF-04856264 and CNV1014802 in a Mouse Model of NaV1.7-Mediated Pain , 2016, Toxins.
[7] Lei Wu,et al. An Efficient Strategy for Heterologous Expression and Purification of Active Peptide Hainantoxin-IV , 2015, PloS one.
[8] C. Cohen,et al. Inhibitors of voltage-gated sodium channel Nav1.7: patent applications since 2010. , 2014, Pharmaceutical patent analyst.
[9] Irina Vetter,et al. No gain, no pain: NaV1.7 as an analgesic target. , 2014, ACS chemical neuroscience.
[10] Zhe Wu,et al. Analgesic effects of Huwentoxin-IV on animal models of inflammatory and neuropathic pain. , 2013, Protein Peptide Letters.
[11] C. Cardoso,et al. Anti-inflammatory effects and acute toxicity of hydroethanolic extract of Jacaranda decurrens roots in adult male rats. , 2012, Journal of ethnopharmacology.
[12] M. Chahine,et al. Differential Expression of Sodium Channel β Subunits in Dorsal Root Ganglion Sensory Neurons* , 2012, The Journal of Biological Chemistry.
[13] Shunyi Zhu,et al. Evolutionary Diversification of Mesobuthus α-Scorpion Toxins Affecting Sodium Channels* , 2011, Molecular & Cellular Proteomics.
[14] Ming Lu,et al. Molecular basis of the tarantula toxin jingzhaotoxin‐III (β‐TRTX‐Cj1α) interacting with voltage sensors in sodium channel subtype Nav1.5 , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] William A Catterall,et al. Structure-Function Map of the Receptor Site for β-Scorpion Toxins in Domain II of Voltage-gated Sodium Channels* , 2011, The Journal of Biological Chemistry.
[16] James O. Jackson,et al. Common Molecular Determinants of Tarantula Huwentoxin-IV Inhibition of Na+ Channel Voltage Sensors in Domains II and IV* , 2011, The Journal of Biological Chemistry.
[17] James O. Jackson,et al. The Tarantula Toxins ProTx-II and Huwentoxin-IV Differentially Interact with Human Nav1.7 Voltage Sensors to Inhibit Channel Activation and Inactivation , 2010, Molecular Pharmacology.
[18] R. Cregg,et al. Pain channelopathies , 2010, The Journal of physiology.
[19] R. Lewis,et al. Use of Venom Peptides to Probe Ion Channel Structure and Function* , 2010, The Journal of Biological Chemistry.
[20] Liping Jiang,et al. Expression and characterization of jingzhaotoxin-34, a novel neurotoxin from the venom of the tarantula Chilobrachys jingzhao , 2009, Peptides.
[21] Martin Koltzenburg,et al. ProTx-II, a Selective Inhibitor of NaV1.7 Sodium Channels, Blocks Action Potential Propagation in Nociceptors , 2008, Molecular Pharmacology.
[22] E. Moczydlowski,et al. Tarantula Huwentoxin-IV Inhibits Neuronal Sodium Channels by Binding to Receptor Site 4 and Trapping the Domain II Voltage Sensor in the Closed Configuration* , 2008, Journal of Biological Chemistry.
[23] Yucheng Xiao,et al. Synthesis and characterization of huwentoxin-IV, a neurotoxin inhibiting central neuronal sodium channels. , 2008, Toxicon : official journal of the International Society on Toxinology.
[24] Nicholas J. Hargus,et al. Voltage-gated Na+ channels in neuropathic pain , 2007, Expert opinion on investigational drugs.
[25] A. Soladoye,et al. Anti-inflammatory activity of aqueous leaf extract of Chromolaena odorata , 2006, InflammoPharmacology.
[26] W. Catterall,et al. International Union of Pharmacology. XLVIII. Nomenclature and Structure-Function Relationships of Voltage-Gated Calcium Channels , 2005, Pharmacological Reviews.
[27] M. Meisler,et al. Sodium channel mutations in epilepsy and other neurological disorders. , 2005, Journal of Clinical Investigation.
[28] J. Peter Gogarten,et al. Were arachnids the first to use combinatorial peptide libraries? , 2005, Peptides.
[29] B. Ding,et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia , 2004, Journal of Medical Genetics.
[30] Yucheng Xiao,et al. Inhibition of neuronal tetrodotoxin-sensitive Na+ channels by two spider toxins: hainantoxin-III and hainantoxin-IV. , 2003, European journal of pharmacology.
[31] W. Catterall,et al. Molecular mechanisms of neurotoxin action on voltage-gated sodium channels. , 2000, Biochimie.
[32] Gail Mandel,et al. Nomenclature of Voltage-Gated Sodium Channels , 2000, Neuron.
[33] W. Catterall,et al. Voltage Sensor–Trapping Enhanced Activation of Sodium Channels by β-Scorpion Toxin Bound to the S3–S4 Loop in Domain II , 1998, Neuron.
[34] S. Priori,et al. Cardiac sodium channel mutations in patients with long QT syndrome, an inherited cardiac arrhythmia. , 1995, Human molecular genetics.